Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its ...

Dyno Therapeutics announces exercise of option by Roche for next-generation AAV vector for neurological gene therapy ...

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding ...

The enduring scientific interest in the brain is highlighted by the donation of Charles Babbage’s brain in 1871. Babbage’s ...

Dupree's new TLC show, "Baylen Out Loud," follows her journey with severe vocal and motor tics as she navigates adulthood, ...

In a recently published article in the journal Stroke, corresponding author, Bernadette Boden-Albala, MPH, DrPH, founding ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

The world needs a leader in brain and spine treatment and research. Ohio State’s Neurological Institute seeks to be that leader. More than 50 million people in the United States and a billion people ...

Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

Readers urge public officials to take action on climate change rather than casting blame. Also: Teflon Don; the Gulf of ...

Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcomes in the months or years after giving birth.